Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
120
Trial Sponsor
Clinical Trial Start Date
2010
0Primary Completion Date
2011
0Study Completion Date
2011
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Diagnostic0
Intervention Type
Drug0
Interventional Trial Phase
Phase 30
Participating Facility
Official Name
A Principal, Prospective, Open-label Biopsy Study to Validate Detection of Cerebral Cortical Amyloid With Flutemetamol (18F) Injection in Normal Pressure Hydrocephalus (NPH) Subjects0
Last Updated
December 13, 2013
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
[18F]Flutemetamol0
Study summary
To determine the level of association between the quantitative estimates of brain uptake of \[18F\]flutemetamol and the quantitative immunohistochemical and histochemistry estimates of amyloid levels in frontal lobe biopsy samples obtained from subjects during shunt placement for NPH.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
